Edit |   |
---|---|
Antigenic Specificity | CD3E & CD123, Human (Flotetuzumab biosimilar) |
Clone | Flotetuzumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | VH-Vl-VH'-Vl' |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD3E & CD123 Recombinant Antibody. Flotetuzumab (INN, development code MGD006) is a bispecific antibody designed for the treatment of acute myeloid leukemia. This drug is being developed by MacroGenics, Inc. |
Immunogen | n/a |
Other Names | Anti-CD3E & CD123 Recombinant Antibody, Research Grade Flotetuzumab, Anti-Human CD3E & CD123 Recombinant Antibody, MGD-006, MGD006, RES234, Antibody Drug Analogues, Monoclonal Antibody, YR1447, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1664355-28-5 |
Catalog # | YR1447 |
Price | please inquire |
Order / More Info | CD3E & CD123, Human (Flotetuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |